Literature DB >> 7706522

Chemical gastritis induced by naproxen in the absence of Helicobacter pylori infection.

C J McCarthy1, M McDermott, D Hourihane, C O'Morain.   

Abstract

AIM: To evaluate the histological changes that occur in the antral mucosa of healthy male subjects before and after one week of naproxen administration, using a chemical gastritis score according to the Helicobacter pylori status.
METHODS: Nineteen male subjects (mean age 31 years) underwent two endoscopies: one before and the other after one week of naproxen treatment (1 g daily). Antral biopsy specimens were assessed for the presence of H pylori infection and for chemical gastritis, defined as the presence of foveolar hyperplasia, muscle fibres in the lamina propria, oedema, and vasodilatation, in the absence of acute or chronic inflammatory cell infiltrate.
RESULTS: Of the 19 subjects, eight had H pylori infection. After one week of naproxen treatment, none of those with H pylori infection developed chemical gastritis, while five of 11 (45%) of those without H pylori infection did. In the absence of H pylori infection there was no evidence of inflammation, either before or after naproxen administration.
CONCLUSIONS: A different pattern of antral histological change occurs following naproxen administration. This pattern is related to the presence or absence of H pylori infection, suggesting that H pylori status should be determined in histological studies of subjects taking non-steroidal anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7706522      PMCID: PMC502265          DOI: 10.1136/jcp.48.1.61

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers.

Authors:  F L Lanza; D G Evans; D Y Graham
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

2.  Campylobacter pylori associated gastritis in patients with rheumatoid arthritis taking nonsteroidal anti-inflammatory drugs.

Authors:  R Upadhyay; A Howatson; A McKinlay; B J Danesh; R D Sturrock; R I Russell
Journal:  Br J Rheumatol       Date:  1988-04

3.  Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.

Authors:  C P Dooley; D McKenna; H Humphreys; S Bourke; C T Keane; E Sweeney; C O'Morain
Journal:  Am J Gastroenterol       Date:  1988-03       Impact factor: 10.864

4.  Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.

Authors:  F L Lanza; G L Royer; R S Nelson
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

5.  Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection.

Authors:  D Y Graham; M D Lidsky; A M Cox; D J Evans; D G Evans; L Alpert; P D Klein; S L Sessoms; P A Michaletz; Z A Saeed
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

6.  Endoscopy in dyspeptic patients: is gastric mucosal biopsy useful?

Authors:  D Vaira; J Holton; J Osborn; L D'Anna; A Romanos; M Falzon; I McNeil
Journal:  Am J Gastroenterol       Date:  1990-06       Impact factor: 10.864

7.  Gastritis in patients on non-steroidal anti-inflammatory drugs.

Authors:  C M Quinn; I Bjarnason; A B Price
Journal:  Histopathology       Date:  1993-10       Impact factor: 5.087

8.  Reflux gastritis in the intact stomach.

Authors:  G M Sobala; R F King; A T Axon; M F Dixon
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

9.  Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin.

Authors:  W L Peterson; E Lee; M Feldman
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

10.  Serological evidence of infection with Helicobacter pylori may predict gastrointestinal intolerance to non-steroidal anti-inflammatory drug (NSAID) treatment in rheumatoid arthritis.

Authors:  S T Jones; R B Clague; J Eldridge; D M Jones
Journal:  Br J Rheumatol       Date:  1991-02
View more
  3 in total

1.  Foveolar hyperplasia at the gastric cardia: prevalence and associations.

Authors:  M Voutilainen; M Juhola; M Färkkilä; P Sipponen
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events.

Authors:  M Frezza; N Gorji; M Melato
Journal:  J Clin Pathol       Date:  2001-07       Impact factor: 3.411

Review 3.  Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?

Authors:  D M McCarthy
Journal:  Yale J Biol Med       Date:  1998 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.